Paraguay Central Bank Keeps Benchmark Rate Unchanged at 6%
Paraguay's central bank kept monetary policy on hold Tuesday, leaving the benchmark rate unchanged at 6%.
The policy meeting marked 15 consecutive months with the key rate steady at 6% thanks to tame consumer prices and anchored inflation expectations. Analysts surveyed by the central bank see no change in borrowing costs through the end of the year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
16 minutes ago
- Bloomberg
Australia's Monthly Inflation Cools, Boosting July Rate-Cut Bets
A gauge of Australia's monthly inflation cooled faster than anticipated in May, moving close to the bottom of the Reserve Bank's 2-3% target and bolstering the case for further interest-rate cuts. The Consumer Price Index indicator advanced 2.1%, compared with economists' estimate of a 2.3% gain, data released by the Australian Bureau of Statistics showed on Wednesday. The headline figure has now been inside the RBA's target for 10 months.
Yahoo
26 minutes ago
- Yahoo
A Look At The Intrinsic Value Of TMK Chemical Bhd (KLSE:TMK)
TMK Chemical Bhd's estimated fair value is RM1.38 based on 2 Stage Free Cash Flow to Equity Current share price of RM1.21 suggests TMK Chemical Bhd is potentially trading close to its fair value The RM2.04 analyst price target for TMK is 48% more than our estimate of fair value In this article we are going to estimate the intrinsic value of TMK Chemical Bhd (KLSE:TMK) by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow. Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To begin with, we have to get estimates of the next ten years of cash flows. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (MYR, Millions) RM82.3m RM86.1m RM89.7m RM93.4m RM97.1m RM100.8m RM104.6m RM108.5m RM112.6m RM116.7m Growth Rate Estimate Source Est @ 4.90% Est @ 4.52% Est @ 4.26% Est @ 4.07% Est @ 3.94% Est @ 3.85% Est @ 3.79% Est @ 3.74% Est @ 3.71% Est @ 3.69% Present Value (MYR, Millions) Discounted @ 9.7% RM75.0 RM71.5 RM67.9 RM64.4 RM61.0 RM57.7 RM54.6 RM51.6 RM48.8 RM46.1 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = RM599m We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (3.6%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 9.7%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = RM117m× (1 + 3.6%) ÷ (9.7%– 3.6%) = RM2.0b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= RM2.0b÷ ( 1 + 9.7%)10= RM784m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is RM1.4b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of RM1.2, the company appears about fair value at a 12% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at TMK Chemical Bhd as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 9.7%, which is based on a levered beta of 1.028. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. See our latest analysis for TMK Chemical Bhd Strength Earnings growth over the past year exceeded the industry. Debt is not viewed as a risk. Dividends are covered by earnings and cash flows. Weakness Dividend is low compared to the top 25% of dividend payers in the Chemicals market. Opportunity Annual revenue is forecast to grow faster than the Malaysian market. Current share price is below our estimate of fair value. Threat Annual earnings are forecast to grow slower than the Malaysian market. Although the valuation of a company is important, it ideally won't be the sole piece of analysis you scrutinize for a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For TMK Chemical Bhd, there are three further aspects you should look at: Financial Health: Does TMK have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk. Future Earnings: How does TMK's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every Malaysian stock every day, so if you want to find the intrinsic value of any other stock just search here. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.2% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
2 hours ago
- Yahoo
Fed's Schmid says there is time to study tariff effects before rate cuts
By Howard Schneider WASHINGTON (Reuters) -The U.S. Federal Reserve has time to study the effect of rising import tariffs on prices and economic growth before deciding on further interest rate cuts, Kansas City Fed President Jeff Schmid said on Tuesday. "The current posture of monetary policy, which has been characterized as 'wait-and-see,' is appropriate," Schmid said in remarks prepared for delivery to an agricultural summit in Nebraska. "The resilience of the economy gives us the time to observe how prices and the economy develop," before changing the benchmark policy rate, said Schmid, a voter this year on the Fed's rate-setting Federal Open Market Committee, which next meets on July 29-30. The Fed has held its benchmark rate steady in a range from 4.25% to 4.5% since December, despite calls from President Donald Trump for rate cuts. Fed officials in recent projections anticipate two rate cuts by the end of the year, but have highlighted uncertainty around trade policy and in general expect to see slower growth, higher unemployment and higher inflation in coming months. Inflation remains above the Fed's 2% target, and "contacts almost uniformly expect increased tariffs to push up prices and to weigh on activity," Schmid said, adding it seemed "likely" the Fed's inflation and job goals "will come into conflict." But "there is far less clarity on when and by how much," said Schmid, an argument for leaving interest rates unchanged until the economy's direction is clearer.
